Genprex GNPX
NASDAQ GNPX
$3.95 -0.04 (-1.00%)
At close: Aug 20, 2026 · 4:00 PM EDT

Genprex (GNPX) EPS (Basic) (2016 - 2025)

Genprex (GNPX) posted quarterly EPS (Basic) of -$49.95 for Q1 2025, up 98.78% year-over-year from -$25.13 in Q1 2024, and up 95.69% quarter-over-quarter from -$1160.1 in Q4 2024.

Genprex (GNPX) EPS (Basic) (2016 - 2025) Analysis & Trends

Genprex's EPS (Basic) history runs 10 years deep, the most recent figure standing at -$49.95 for Q1 2025.

  • In Q1 2025, EPS (Basic) rose 98.78% year-over-year to -$49.95; the TTM figure through Dec 2025 stood at -$16.35 (up 99.72% YoY), while the FY2025 annual figure was -$382.79, up 93.48% from the prior year.
  • EPS (Basic) for Q1 2025 stood at -$49.95, up from -$1160.1 in the prior quarter.
  • The five-year high for EPS (Basic) was -$49.95 in Q1 2025, with the low at -$8237.7 in Q1 2023.
  • The 5-year median for EPS (Basic) is -$4880.3 (2022), against an average of -$4463.3.
  • The sharpest annual moves came in 2022 and 2025: EPS (Basic) sank 77.94% in 2022, then jumped 98.78% in 2025.
  • Genprex's EPS (Basic) stood at -$6309.6 in 2021, then advanced by 4.81% to -$6006.0 in 2022, then grew by 20.31% to -$4786.2 in 2023, then surged by 75.76% to -$1160.1 in 2024, then surged by 95.69% to -$49.95 in 2025.
  • Business Quant data shows GNPX's EPS (Basic) at -$49.95 in Q1 2025, -$1160.1 in Q4 2024, and -$1366.2 in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 12.62
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 7.59
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -1.96
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 2.12
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 1.23
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn -0.06
8 Royalty Pharma 26.98 Bn 26.14 Bn - 0.18
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn -0.72
10 Genprex 1.89 Mn -13.27 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2025 -49.95
Dec 31, 2024 -1,160.12
Sep 30, 2024 -1,366.21
Jun 30, 2024 -3,324.05
Mar 31, 2024 -4,083.20
Dec 31, 2023 -4,786.25
Sep 30, 2023 -5,909.25
Jun 30, 2023 -6,782.52
Mar 31, 2023 -8,237.66
Dec 31, 2022 -6,005.96
Sep 30, 2022 -5,653.71
Jun 30, 2022 -5,318.65
Mar 31, 2022 -4,880.35
Dec 31, 2021 -6,309.60
Sep 30, 2021 -3,177.32
Jun 30, 2021 -3,701.13
Mar 31, 2021 -5,130.26
Dec 31, 2020 -6,478.70
Sep 30, 2020 -3,124.94
Jun 30, 2020 -5,439.42